C

Changchun High & New Technology Industries Group Inc
SZSE:000661

Watchlist Manager
Changchun High & New Technology Industries Group Inc
SZSE:000661
Watchlist
Price: 109.6 CNY -3.02% Market Closed
Market Cap: 44.4B CNY
Have any thoughts about
Changchun High & New Technology Industries Group Inc?
Write Note

Changchun High & New Technology Industries Group Inc
Common Shares Outstanding

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Changchun High & New Technology Industries Group Inc
Common Shares Outstanding Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Common Shares Outstanding CAGR 3Y CAGR 5Y CAGR 10Y
C
Changchun High & New Technology Industries Group Inc
SZSE:000661
Common Shares Outstanding
ÂĄ404.4m
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
3%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Common Shares Outstanding
ÂĄ5.9B
CAGR 3-Years
0%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Common Shares Outstanding
ÂĄ603.3m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Common Shares Outstanding
ÂĄ6.4B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Common Shares Outstanding
ÂĄ1.8B
CAGR 3-Years
0%
CAGR 5-Years
11%
CAGR 10-Years
6%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Common Shares Outstanding
ÂĄ401m
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Changchun High & New Technology Industries Group Inc
Glance View

Market Cap
44.3B CNY
Industry
Pharmaceuticals

Changchun High & New Technology Industries (Group), Inc. engages in the research, development, production, and sale of biopharmaceuticals and proprietary Chinese medicines. The company is headquartered in Changchun, Jilin and currently employs 8,045 full-time employees. The Company’s main products include polyethylene glycol recombinant human growth hormone injection, recombinant human growth hormone, recombinant human follicle stimulating hormone for injection, freeze-dried live attenuated varicella vaccines and rabies vaccines for human use, among other. The firm is also involved in real estate development and property management businesses. The firm operates its business mainly in domestic market.

Intrinsic Value
186.04 CNY
Undervaluation 41%
Intrinsic Value
Price
C

See Also

What is Changchun High & New Technology Industries Group Inc's Common Shares Outstanding?
Common Shares Outstanding
404.4m CNY

Based on the financial report for Sep 30, 2024, Changchun High & New Technology Industries Group Inc's Common Shares Outstanding amounts to 404.4m CNY.

What is Changchun High & New Technology Industries Group Inc's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
3%

Over the last year, the Common Shares Outstanding growth was 1%.

Back to Top